Shilanski & Associates’s Abbott ABT Stock Holding History

Shilanski & Associates’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,584	Closed	-$250K	–	114
2022 Q3	$250K	Buy	+2,584	New	+$275K	0.09%	116

Other funds holding ABT

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shilanski & Associates's ABT Position: Q4 2022 in Review

Shilanski & Associates sold out of Abbott (ABT) in Q4 2022, closing a stake of 2,584 shares — an estimated $250K sold.

Shilanski & Associates first reported a position in ABT in Q3 2022 and held it in 1 quarter. The position peaked at $250K in Q3 2022. 2,764 funds tracked by Wall St. Rank hold ABT as of Q4 2022.

Shilanski & Associates reported no remaining Abbott position as of Q4 2022 after selling out during the quarter.
Shilanski & Associates sold 2,584 Abbott shares in Q4 2022, an estimated $250K.
Shilanski & Associates first reported a position in Abbott in Q3 2022 and held it in 1 quarter.
Shilanski & Associates's Abbott position peaked at $250K in Q3 2022.
2,764 funds tracked by Wall St. Rank held Abbott as of Q4 2022.

Based on Shilanski & Associates's 13F filing for Q4 2022, filed 31 Jan 2023.